Evonik to launch restructuring second phase in 2027
Evonik said it will launch the second phase of its restructuring programme in 2027, including sales of two businesses, with the next phase running through 2029.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
2 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
Evonik to launch second phase of restructuring in 2027, plans unit sales
Evonik plans to divest Oxeno and Syneqt, which together employ about 4,300 people. The sale process for Syneqt is set to begin in 2027, while talks with investors regarding Oxeno are underway.